COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Email to Gilles Gagnon on March 7, 2024

<< Previous

Bullboard Posts

Next >>

Comment by Stinzoon Nov 21, 2024 6:21am

23 Views

Post# 36323220

RE:RE:RE:RE:Email to Gilles Gagnon on March 7, 2024

Thank you very much Oats for the background.

Even if you had not shared, i think most long term shareholders would have come to a similar conclusion.

Very sad, for all the lost money and opportunities.

Besides hoping, where do we go from here? With a board not concerned about shareholders interest, what else can be done?

Hard to convince to buy more shares when we know how the management has treated us.